Tenaya Therapeutics Stock Price Prediction

TNYA Stock  USD 2.38  0.22  10.19%   
The RSI of Tenaya Therapeutics' the stock price is about 66. This usually implies that the stock is rather overbought by investors at this time. The main point of the Relative Strength Index (RSI) is to track how fast people are buying or selling Tenaya, making its price go up or down.

Oversold Vs Overbought

66

 
Oversold
 
Overbought
The successful prediction of Tenaya Therapeutics' future price could yield a significant profit. We analyze noise-free headlines and recent hype associated with Tenaya Therapeutics, which may create opportunities for some arbitrage if properly timed. Below are the key fundamental drivers impacting Tenaya Therapeutics' stock price prediction:
EPS Estimate Next Quarter
(0.40)
EPS Estimate Current Year
(1.33)
EPS Estimate Next Year
(1.26)
Wall Street Target Price
18.75
EPS Estimate Current Quarter
(0.37)
Using Tenaya Therapeutics hype-based prediction, you can estimate the value of Tenaya Therapeutics from the perspective of Tenaya Therapeutics response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Tenaya Therapeutics to buy its stock at a price that has no basis in reality. In that case, they are not buying Tenaya because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.

Tenaya Therapeutics after-hype prediction price

    
  USD 2.16  
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
  
Check out Tenaya Therapeutics Basic Forecasting Models to cross-verify your projections.
For information on how to trade Tenaya Stock refer to our How to Trade Tenaya Stock guide.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Tenaya Therapeutics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Intrinsic
Valuation
LowRealHigh
0.091.838.59
Details
Naive
Forecast
LowNextHigh
0.041.918.67
Details
9 Analysts
Consensus
LowTargetHigh
19.4121.3323.68
Details
Earnings
Estimates (0)
LowProjected EPSHigh
-0.35-0.33-0.28
Details

Tenaya Therapeutics After-Hype Price Prediction Density Analysis

As far as predicting the price of Tenaya Therapeutics at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Tenaya Therapeutics or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Tenaya Therapeutics, with the unreliable approximations that try to describe financial returns.
   Next price density   
       Expected price to next headline  

Tenaya Therapeutics Estimiated After-Hype Price Volatility

In the context of predicting Tenaya Therapeutics' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Tenaya Therapeutics' historical news coverage. Tenaya Therapeutics' after-hype downside and upside margins for the prediction period are 0.11 and 8.92, respectively. We have considered Tenaya Therapeutics' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
2.38
2.16
After-hype Price
8.92
Upside
Tenaya Therapeutics is dangerous at this time. Analysis and calculation of next after-hype price of Tenaya Therapeutics is based on 3 months time horizon.

Tenaya Therapeutics Stock Price Prediction Analysis

Have you ever been surprised when a price of a Company such as Tenaya Therapeutics is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Tenaya Therapeutics backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Tenaya Therapeutics, there might be something going there, and it might present an excellent short sale opportunity.
Expected ReturnPeriod VolatilityHype ElasticityRelated ElasticityNews DensityRelated DensityExpected Hype
  0.09 
6.89
  0.02 
 0.00  
6 Events / Month
12 Events / Month
In about 6 days
Latest traded priceExpected after-news pricePotential return on next major newsAverage after-hype volatility
2.38
2.16
0.00 
4,053  
Notes

Tenaya Therapeutics Hype Timeline

Tenaya Therapeutics is at this time traded for 2.38. The entity has historical hype elasticity of -0.02, and average elasticity to hype of competition of 0.0. Tenaya is anticipated not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is over 100%. The immediate return on the next news is anticipated to be very small, whereas the daily expected return is at this time at -0.09%. %. The volatility of related hype on Tenaya Therapeutics is about 12527.27%, with the expected price after the next announcement by competition of 2.38. About 74.0% of the company shares are owned by institutional investors. The company has price-to-book ratio of 1.52. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Tenaya Therapeutics recorded a loss per share of 1.44. The entity had not issued any dividends in recent years. Given the investment horizon of 90 days the next anticipated press release will be in about 6 days.
Check out Tenaya Therapeutics Basic Forecasting Models to cross-verify your projections.
For information on how to trade Tenaya Stock refer to our How to Trade Tenaya Stock guide.

Tenaya Therapeutics Related Hype Analysis

Having access to credible news sources related to Tenaya Therapeutics' direct competition is more important than ever and may enhance your ability to predict Tenaya Therapeutics' future price movements. Getting to know how Tenaya Therapeutics' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Tenaya Therapeutics may potentially react to the hype associated with one of its peers.
Hype
Elasticity
News
Density
Semi
Deviation
Information
Ratio
Potential
Upside
Value
At Risk
Maximum
Drawdown
BCYCBicycle Therapeutics 0.15 9 per month 0.00 (0.04) 4.68 (3.70) 35.92 
IGMSIGM Biosciences 0.49 9 per month 0.00 (0.02) 11.62 (9.42) 41.11 
GLUEMonte Rosa Therapeutics(0.25)7 per month 4.44  0.06  10.11 (8.29) 102.66 
STOKStoke Therapeutics(0.04)7 per month 0.00 (0.12) 4.68 (7.09) 21.35 
BMEABiomea Fusion 0.39 11 per month 4.66  0.01  9.63 (8.16) 24.87 
AKROAkero Therapeutics(1.61)7 per month 2.68  0.06  5.23 (4.45) 13.37 
FIXXHomology Medicines(0.01)2 per month 3.52  0.01  5.77 (5.61) 19.43 
GOSSGossamer Bio 0.00 7 per month 0.00 (0.18) 5.94 (5.21) 17.73 
RANIRani Therapeutics Holdings(0.12)5 per month 0.00 (0.02) 9.21 (9.34) 90.76 
VINCVincerx Pharma(0.23)4 per month 0.00 (0.23) 6.06 (7.69) 48.57 
CRVSCorvus Pharmaceuticals 0.30 9 per month 3.07  0.24  9.38 (4.88) 23.11 
ALXOAlx Oncology Holdings(0.09)6 per month 0.00 (0.22) 6.94 (7.76) 22.71 
EYENEyenovia 0.01 10 per month 0.00 (0.11) 14.29 (17.07) 92.81 
DRTSAlpha Tau Medical(0.09)5 per month 2.24  0  5.41 (3.78) 13.41 
OCULOcular Therapeutix 0.38 10 per month 0.00 (0.05) 6.07 (5.33) 19.78 
INZYInozyme Pharma(0.16)8 per month 0.00 (0.29) 5.68 (7.92) 16.62 

Tenaya Therapeutics Additional Predictive Modules

Most predictive techniques to examine Tenaya price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Tenaya using various technical indicators. When you analyze Tenaya charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About Tenaya Therapeutics Predictive Indicators

The successful prediction of Tenaya Therapeutics stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Tenaya Therapeutics, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Tenaya Therapeutics based on analysis of Tenaya Therapeutics hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Tenaya Therapeutics's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Tenaya Therapeutics's related companies.
 2021 2022 2023 2024 (projected)
Current Ratio11.737.994.914.66
Net Debt To EBITDA0.360.70.270.26

Story Coverage note for Tenaya Therapeutics

The number of cover stories for Tenaya Therapeutics depends on current market conditions and Tenaya Therapeutics' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Tenaya Therapeutics is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Tenaya Therapeutics' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.

Tenaya Therapeutics Short Properties

Tenaya Therapeutics' future price predictability will typically decrease when Tenaya Therapeutics' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Tenaya Therapeutics often depends not only on the future outlook of the potential Tenaya Therapeutics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Tenaya Therapeutics' indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding73.8 M
Cash And Short Term Investments104.6 M

Complementary Tools for Tenaya Stock analysis

When running Tenaya Therapeutics' price analysis, check to measure Tenaya Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Tenaya Therapeutics is operating at the current time. Most of Tenaya Therapeutics' value examination focuses on studying past and present price action to predict the probability of Tenaya Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Tenaya Therapeutics' price. Additionally, you may evaluate how the addition of Tenaya Therapeutics to your portfolios can decrease your overall portfolio volatility.
Global Correlations
Find global opportunities by holding instruments from different markets
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Bonds Directory
Find actively traded corporate debentures issued by US companies